FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

39818011000001107: Cabazitaxel monohydrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jul 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1843581000001115 Cabazitaxel monohydrate en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1843591000001118 Cabazitaxel monohydrate (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabazitaxel monohydrate Is a Taxane derivative true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cabazitaxel 50mg/5ml solution for infusion vials Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml solution for infusion vials Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 60mg/6ml solution for infusion vials Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml solution for infusion vials 1 vial Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 60mg/6ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) 1 vial Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 50mg/5ml solution for infusion vials 1 vial Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 60mg/6ml solution for infusion vials 1 vial Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 50mg/5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 50mg/5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) 1 vial Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 45mg/4.5ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) 1 vial Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier
Cabazitaxel 60mg/6ml concentrate for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient True Cabazitaxel monohydrate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start